Deep Genomics
2015
FOUNDED
PRIVATE
STATUS
11-20
EMPLOYEES
Series A
LATEST DEAL TYPE
$13M
LATEST DEAL AMOUNT
8
INVESTORS
Description
Developer of an integrated genetic computational system designed to interpret genetic variation. The company's integrated genetic computational system alters crucial cellular processes, including transcription, splicing, polyadenylation and translation, leading to effective therapies, enabling researchers to classify, prioritize, interpret and link genetic variants, whether natural or therapeutic.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Software
Primary Office
- MaRS Centre, Heritage Building
- Suite 320
- Toronto, Ontario M5G 1L7
- Canada
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Deep Genomics’s full profile, request a free trial.
Deep Genomics Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 14-Aug-2017 | $13M | 000.00 | Completed | Startup | |
| 2. Seed Round | 18-Nov-2015 | 00.000 | 00.000 | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Deep Genomics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Khosla Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| MaRS Innovation | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 | ||
| 11.2 Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Bloomberg Beta | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| True Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
Deep Genomics Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Brendan Frey Ph.D | Co-Founder, Chief Executive Officer & President |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »